MYCELX Technologies Corporation (MYX) - Net Assets

Latest as of June 2025: GBX3.38 Million GBX ≈ $410.64 USD

Based on the latest financial reports, MYCELX Technologies Corporation (MYX) has net assets worth GBX3.38 Million GBX (≈ $410.64 USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX10.22 Million ≈ $1.24K USD) and total liabilities (GBX6.85 Million ≈ $833.20 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read MYCELX Technologies Corporation total liabilities for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX3.38 Million
% of Total Assets 33.01%
Annual Growth Rate 16.15%
5-Year Change -61.84%
10-Year Change -76.07%
Growth Volatility 347.23

MYCELX Technologies Corporation - Net Assets Trend (2008–2024)

This chart illustrates how MYCELX Technologies Corporation's net assets have evolved over time, based on quarterly financial data. Also explore MYX current and non-current assets for the complete picture of this company's asset base.

Annual Net Assets for MYCELX Technologies Corporation (2008–2024)

The table below shows the annual net assets of MYCELX Technologies Corporation from 2008 to 2024. For live valuation and market cap data, see MYX stock market capitalisation.

Year Net Assets Change
2024-12-31 GBX5.26 Million
≈ $640.35		 -26.46%
2023-12-31 GBX7.16 Million
≈ $870.80		 -33.93%
2022-12-31 GBX10.83 Million
≈ $1.32K		 -14.18%
2021-12-31 GBX12.62 Million
≈ $1.54K		 -8.48%
2020-12-31 GBX13.79 Million
≈ $1.68K		 -30.50%
2019-12-31 GBX19.84 Million
≈ $2.41K		 -5.38%
2018-12-31 GBX20.97 Million
≈ $2.55K		 +17.73%
2017-12-31 GBX17.82 Million
≈ $2.17K		 -5.45%
2016-12-31 GBX18.84 Million
≈ $2.29K		 -14.35%
2015-12-31 GBX22.00 Million
≈ $2.68K		 -12.10%
2014-12-31 GBX25.02 Million
≈ $3.04K		 +31.37%
2013-12-31 GBX19.05 Million
≈ $2.32K		 +15.77%
2012-12-31 GBX16.45 Million
≈ $2.00K		 -6.39%
2011-12-31 GBX17.58 Million
≈ $2.14K		 +1431.41%
2010-12-31 GBX1.15 Million
≈ $139.64		 +41.67%
2009-12-31 GBX810.07K
≈ $98.56		 +68.85%
2008-12-31 GBX479.75K
≈ $58.37		 --

Equity Component Analysis

This analysis shows how different components contribute to MYCELX Technologies Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 3548970660.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock GBX609.00K 11.57%
Other Components GBX45.59 Million 866.29%
Total Equity GBX5.26 Million 100.00%

MYCELX Technologies Corporation Competitors by Market Cap

The table below lists competitors of MYCELX Technologies Corporation ranked by their market capitalization.

Company Market Cap
React Group PLC
LSE:REAT
 $133.73K
Reabold Resources Plc
LSE:RBD
 $133.96K
Matahari Department Store Tbk
JK:LPPF
 $134.15K
Empresaria Group plc
LSE:EMR
 $134.28K
Caffyns PLC
LSE:CFYN
 $132.71K
AETHER CATALYST SOLUT.
F:2QZ
 $132.28K
Zinc Media Group
LSE:ZIN
 $131.77K
REVEZ CORPORATION LTD.
F:7IQ
 $131.66K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MYCELX Technologies Corporation's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 7,157,000 to 5,263,000, a change of -1,894,000 (-26.5%).
  • Net loss of 2,723,000 reduced equity.
  • New share issuances of 792,000 increased equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income GBX-2.72 Million -51.74%
Share Issuances GBX792.00K +15.05%
Other Changes GBX37.00K +0.7%
Total Change GBX- -26.46%

Book Value vs Market Value Analysis

This analysis compares MYCELX Technologies Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 200.33x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 1212.17x to 200.33x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2008-12-31 GBX0.04 GBX45.00 x
2009-12-31 GBX0.06 GBX45.00 x
2010-12-31 GBX0.09 GBX45.00 x
2011-12-31 GBX1.92 GBX45.00 x
2012-12-31 GBX1.27 GBX45.00 x
2013-12-31 GBX1.33 GBX45.00 x
2014-12-31 GBX1.84 GBX45.00 x
2015-12-31 GBX1.18 GBX45.00 x
2016-12-31 GBX1.00 GBX45.00 x
2017-12-31 GBX0.95 GBX45.00 x
2018-12-31 GBX1.05 GBX45.00 x
2019-12-31 GBX1.03 GBX45.00 x
2020-12-31 GBX0.71 GBX45.00 x
2021-12-31 GBX0.65 GBX45.00 x
2022-12-31 GBX0.49 GBX45.00 x
2023-12-31 GBX0.31 GBX45.00 x
2024-12-31 GBX0.22 GBX45.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently MYCELX Technologies Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -51.74%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -55.54%
  • • Asset Turnover: 0.49x
  • • Equity Multiplier: 1.91x
  • Recent ROE (-51.74%) is below the historical average (-9.43%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2008 72.95% 13.09% 1.93x 2.88x GBX301.99K
2009 22.16% 7.00% 1.80x 1.76x GBX98.47K
2010 29.60% 7.90% 1.93x 1.94x GBX224.99K
2011 -15.72% -44.16% 0.33x 1.09x GBX-4.52 Million
2012 -12.01% -16.07% 0.63x 1.18x GBX-3.62 Million
2013 2.97% 2.64% 0.77x 1.45x GBX-1.34 Million
2014 -23.66% -43.59% 0.41x 1.33x GBX-8.42 Million
2015 -16.59% -26.85% 0.54x 1.15x GBX-5.85 Million
2016 -17.40% -41.39% 0.35x 1.19x GBX-5.16 Million
2017 -6.50% -8.42% 0.64x 1.21x GBX-2.94 Million
2018 14.64% 11.39% 0.96x 1.33x GBX972.70K
2019 -14.91% -24.85% 0.49x 1.23x GBX-4.94 Million
2020 -44.19% -85.78% 0.37x 1.39x GBX-7.47 Million
2021 -11.29% -16.81% 0.54x 1.24x GBX-2.69 Million
2022 -36.84% -39.81% 0.74x 1.26x GBX-5.07 Million
2023 -51.78% -33.98% 1.05x 1.45x GBX-4.42 Million
2024 -51.74% -55.54% 0.49x 1.91x GBX-3.25 Million

Industry Comparison

This section compares MYCELX Technologies Corporation's net assets metrics with peer companies in the Pollution & Treatment Controls industry.

Industry Context

  • Industry: Pollution & Treatment Controls
  • Average net assets among peers: $41,184,000
  • Average return on equity (ROE) among peers: 6.97%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
MYCELX Technologies Corporation (MYX) GBX3.38 Million 72.95% 2.03x $133.40K
Porvair plc (PRV) $41.18 Million 6.97% 0.80x $4.09 Million

About MYCELX Technologies Corporation

LSE:MYX UK Pollution & Treatment Controls
Market Cap
$133.40K
GBX1.10 Billion GBX
Market Cap Rank
#30914 Global
#1067 in UK
Share Price
GBX45.00
Change (1 day)
+0.00%
52-Week Range
GBX18.60 - GBX47.00
All Time High
GBX270.00
Categories
Companies in UK Pollution & Treatment Controls
About

MYCELX Technologies Corporation, a clean water technology company, provides water treatment solutions to the PFAS remediation and produced water markets in the Middle East, the United States, Australia, and internationally. The company also sells and leases its equipment; and sells filtration media. It serves the oil and gas, power, marine, and heavy manufacturing sectors. The company was incorpo… Read more